Plain-English translation of NCT05391126 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Colorectal Cancer research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing whether a personalized approach to dosing cancer medications works better than standard dosing. Researchers will first test your genes to see how your body processes a cancer drug called . Then, half of participants will receive doses tailored to their genetic makeup, while the other half will receive standard doses.
Some people's bodies process cancer medications differently based on their genes, which can affect how well the treatment works and what side effects they experience. This trial wants to see if customizing medication doses to match each person's genes leads to better outcomes.
You likely qualify if…
You likely don't qualify if…
You will have a genetic test to determine how your body processes cancer medications. Based on your results, you will be randomly assigned to either receive personalized medication doses based on your genes or standard doses. You will then receive your assigned cancer treatment and be monitored by the study team to see how well it works and what side effects you experience.
AI-generated summary from trial data · Jul 9, 2026 · Not medical advice
United States